Sermorelin Therapy
GHRH Pre-Cursor Secretagogue Analog (Sermorelin)
Sermorelin is a biological active analog of growth hormone releasing hormone (GHRH) that is produced by the human brain to stimulate production and release of growth hormone by the pituitary gland. During youth, ample amounts of GHRH are produced so that the pituitary is able to provide the body with sufficient growth hormone to sustain health, vitality and otherwise normal aspects of form and function. However, during aging, GHRH declines causing reduced production and secretion of pituitary hGH and thereby increasing the sequelae of growth hormone insufficiency that erodes health, vigor and vitality during later life.
Semorelin is the acetate salt of an imitated synthetic amino acid polypeptide, consisting of the first 29 of 44 amino acids of naturally occurring Human Growth Hormone-releasing hormone (GH-H) in the body. Semorelin acetate is the last of the hypothalmic-releasing hormones to be identified and characterized, and represents the shortest fragment of GH-RH known to possess the full biological activity of the parent hormone known as Human Growth Hormone-releasing hormone (GH-H).
In contrast to increasing growth hormone levels by the injection of bio-synthetic or Bio-identical Human Growth Hormone, GH-RH injections increase plasma growth hormone concentrations in patients with idiopathic growth hormone deficiency, by directly stimulating the pituitary gland to release natural Human Growth Hormone. Semorelin acetate for injection (GH-RH ) is similar to natural GH-RH with respect to its ability to stimulate HGH secretions in humans.
GH-RH for injection has been effective in the treatment of growth hormone deficiency in children. The clinic anticipates that GH-RH will also be effective in the treatment of adult growth hormone deficiency because it has been effective in the treatment of children, and because HGH has already proven itself to effective in cases of adult growth hormone deficiency. The GH-RH used by the clinic has been studied for 12 years in more than 70 clinical trials in over 2,600 child patients totaling more than 485 patient years of treatment.
Growth hormone releasing hormone for injection was approved for use in children by the FDA in 1997, and became available to the clinic in 1998. It is an experimental clinic treatment with regards to adult patients who are prescribed about half the dose of a small child. Prior clinic approval is required to participate in the adult clinical trial program conducted by the clinic. This therapy has great potential for adults who have growth hormone deficiency and seek to reverse the effects of aging or treat a medical disorder. A patient who is unsatisfied with the results obtained through GH-GH therapy may elect to be treated thereafter with HGH replacement therapy or vice versa.
Typically each bottle of Sermorelin, we have you put 3cc’s (3ml) of the bacteria static water into it. This is done by tilting the bottle to a 45 degree angle and allowing the water to drip in from the needle slowly so there is no foaming, contact us for the specific protocol for mixing the bacteria static water with the sermorelin white powder to create a clear liquid sermorelin which is used for injecting.
Doing a dose of 300mcg a night, you would pull 30 on the insulin needle – this dose would make one bottle last 10 days, thus it would take 3 bottles to last one month
Doing a dose of 200mcg a night, you would pull 20 on the insulin needle, this dose would last 15 days and thus, it would take 2 bottles to last one month.
